Literature DB >> 34523728

Do peripheral protein oligomers in neurodegenerative diseases shape T cell responses beyond the brain?

Annabelle Ferguson1, Simon Milling1.   

Abstract

Neurodegenerative diseases place a devastating burden on affected individuals and their families, and new treatments are desperately needed for these common immune-mediated inflammatory conditions. While large aggregates of abnormal proteins in the brain cause significant damage, it is becoming clear that smaller soluble protein aggregates can also contribute to disease, by both direct and indirect mechanisms. These soluble protein oligomers can be found in patients' serum. Here, we describe recent research that identifies effects of model oligomer molecules on peripheral blood T cells, therefore providing an additional mechanism by which neurodegeneration may be worsened through amplification of peripheral adaptive immune responses.
© 2021 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34523728      PMCID: PMC8442234          DOI: 10.1111/imm.13414

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.215


  10 in total

1.  A causative link between the structure of aberrant protein oligomers and their toxicity.

Authors:  Silvia Campioni; Benedetta Mannini; Mariagioia Zampagni; Anna Pensalfini; Claudia Parrini; Elisa Evangelisti; Annalisa Relini; Massimo Stefani; Christopher M Dobson; Cristina Cecchi; Fabrizio Chiti
Journal:  Nat Chem Biol       Date:  2010-01-10       Impact factor: 15.040

Review 2.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

3.  The history of Parkinson's disease: early clinical descriptions and neurological therapies.

Authors:  Christopher G Goetz
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 4.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

5.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

6.  The discovery of Alzheimer's disease.

Authors:  Hanns Hippius; Gabriele Neundörfer
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

Review 7.  Neuroimmunology - the past, present and future.

Authors:  E Nutma; H Willison; G Martino; S Amor
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

8.  Innate immune memory in the brain shapes neurological disease hallmarks.

Authors:  Ann-Christin Wendeln; Karoline Degenhardt; Lalit Kaurani; Michael Gertig; Thomas Ulas; Gaurav Jain; Jessica Wagner; Lisa M Häsler; Katleen Wild; Angelos Skodras; Thomas Blank; Ori Staszewski; Moumita Datta; Tonatiuh Pena Centeno; Vincenzo Capece; Md Rezaul Islam; Cemil Kerimoglu; Matthias Staufenbiel; Joachim L Schultze; Marc Beyer; Marco Prinz; Mathias Jucker; André Fischer; Jonas J Neher
Journal:  Nature       Date:  2018-04-11       Impact factor: 49.962

9.  Distinct responses of human peripheral blood cells to different misfolded protein oligomers.

Authors:  Magdalena Leal-Lasarte; Benedetta Mannini; Fabrizio Chiti; Michele Vendruscolo; Christopher M Dobson; Cintia Roodveldt; David Pozo
Journal:  Immunology       Date:  2021-05-27       Impact factor: 7.397

Review 10.  Towards PET imaging of the dynamic phenotypes of microglia.

Authors:  Wissam Beaino; Bieneke Janssen; Danielle J Vugts; Helga E de Vries; Albert D Windhorst
Journal:  Clin Exp Immunol       Date:  2021-08-16       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.